K022053

Substantially Equivalent

HYDRAGEL 7 LIPOPROTEIN(E), PN 4114 & HYDRAGEL LIPOPROTEIN(E) 15/30 PN 4134

Applicant: Sebia
Product code: JHO
Advisory panel: Clinical Chemistry
Date received: 2002-06-24
Decision date: 2002-07-12
Decision: Substantially Equivalent
Clearance type: Special
Location: Chelsea, MI, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.